| 1-F31-EB035917-01 |
Co-engineering Synthetically Programmed Cells and Biomaterials for Regenerative Medicine |
Joanne Lee |
Vanderbilt University |
| 5-R01-EB026510-06 |
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programs |
Joshua Leonard |
Northwestern University |
| 5-R21-EB030036-03 |
Development of a "Cell Splicing" Technology Platform |
Joshua Doloff |
Johns Hopkins University |
| 5-R21-EB033892-02 |
Engineered Probiotics for Closed-Loop Control of Disease-Associated Gut Metabolites in Gut-On-Chip Models |
Benjamin Woolston |
Northeastern University |
| 7-R21-EB030769-02 |
Engineering Probiotics to Sense and Respond to the Intracellular Redox Imbalances towards Mitochondrial Dysfunction |
Jiahe Li |
University of Michigan at Ann Arbor |
| 5-R01-EB029750-04 |
Engineering S. typhimurium for metastatic colorectal cancer |
Tal Danino |
Columbia Univ New York Morningside |
| 5-R01-EB028532-04 |
Integration of systems and synthetic biology to advance development of human tissues ex vivo |
Mo Ebrahimkhani |
University of Pittsburgh at Pittsburgh |
| 5-R01-EB030340-04 |
Model-guided design of next-generation bacterial therapeutics to treat cardiovascular disease |
Ophelia Venturelli |
University of Wisconsin-Madison |
| 5-R01-EB030352-04 |
Probiotic guided CAR-T therapy (ProCARs) for breast cancer |
Tal Danino |
Columbia Univ New York Morningside |
| 1-R01-EB034302-01 |
Programmable encapsulation systems to improve delivery of therapeutic bacteria |
Tal Danino |
Columbia Univ New York Morningside |
